No Child Left Undiagnosed

“We envision a world where every child and every patient who requires a diagnosis receives one, in time for it to make a difference.” Reid Robison, MD CEO of Tute Genomics LAYING THE FOUNDATION FOR PRECISION MEDICINE “The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will … Continue reading No Child Left Undiagnosed

A disease may be rare, but finding answers should not be.

Every day, over 300 million families across the globe wake up to another battle against rare diseases. There are over 7000 known rare diseases, with more being discovered all time. While these conditions may be individually rare (i.e. less than 1/200,000 people), when you put them together, having a rare disease is all too common. … Continue reading A disease may be rare, but finding answers should not be.

CEO Reid Robison Discusses Tute Genomics with StartUp Health Now

CEO Reid Robison met with StartUp Health Now to discuss the founding and ongoing development and growth of Tute Genomics. Robison commented that, “One thing that I really like to emphasize is that, you’ve got to believe 100 percent in your idea or it’s not worth doing…Luckily, it’s a good time to be, not only … Continue reading CEO Reid Robison Discusses Tute Genomics with StartUp Health Now

Tute Genomics Welcomes New VP of Marketing Josh Forsythe

We have officially announced the tremendous addition of Josh Forsythe to our Tute team as Vice President of Marketing. We are thrilled to have such expertise and knowledge driving our marketing department. CEO, Reid Robison, shared his excitement about having Josh aboard saying, “Josh’s vast experience commercializing software technology in a highly complex and evolving … Continue reading Tute Genomics Welcomes New VP of Marketing Josh Forsythe

Tute Selected as Utah Innovation Award Recipient

We’re honored to have been selected for a Utah Innovation Award in the Life Science/BioTech category. Here’s some more information from Utah Business about our innovative technology: “Every human has about three billion base pairs in his or her DNA—far too much data to analyze with a simple Excel spreadsheet. That’s where Tute Genomics’ cloud-based genomic … Continue reading Tute Selected as Utah Innovation Award Recipient

Improve Diagnostic Rates, Speed Up Turnaround Times, Reduce Costs

You need fast, accurate answers to your most difficult-to-interpret genomic variants. We are here to help! Introducing ‘Expert Review’ by Tute Genomics, a new, supplementary service to our precision medicine platform that provides the necessary decision support to ensure you interpret variants faster and solve challenging cases sooner. Expert Review is a manual review of individual … Continue reading Improve Diagnostic Rates, Speed Up Turnaround Times, Reduce Costs

Exploring Genetic Variation with Google Genomics and Tute

Human genome sequencing is fast becoming standard practice for both clinicians and researchers now that the cost to read all 3 billion letters of a person’s DNA has dropped to just a few thousand dollars. But what does all that information mean for medicine and health? At Tute Genomics we’re answering that question by building … Continue reading Exploring Genetic Variation with Google Genomics and Tute

PRESS RELEASE: Tute Genomics and DNAnexus Team Up to Provide Integrated Sample-in, Report-out Genome Analysis Pipeline

PROVO, Utah and MOUNTAIN VIEW, Calif., March 17, 2015 — DNAnexus, a pioneer in cloud-based genome informatics and data management, and Tute Genomics, a leading genome annotation and interpretation platform, today announced an integrated solution for genomic data management. Customers will be able to access the Tute platform and DNAnexus pipelines from either company’s cloud environment. DNAnexus … Continue reading PRESS RELEASE: Tute Genomics and DNAnexus Team Up to Provide Integrated Sample-in, Report-out Genome Analysis Pipeline

CEO Reid Robison on the Cover of Utah Business Mag, Tute named a “Company to watch”

Extensive backgrounds in genomics and a realization that the healthcare world needed more personalized medicine are what led Dr. Reid Robison, CEO of Tute Genomics, and Dr. Kai Wang, president of Tute Genomics, to found their Provo-based business in 2012. Robison has a background at the University of Utah, where he joined as faculty and … Continue reading CEO Reid Robison on the Cover of Utah Business Mag, Tute named a “Company to watch”

PRESS RELEASE: Tute Genomics Shares Database of 8.5 Billion Genetic Variants on Google Genomics

March 12, 2015 | Google Genomics wants to play seriously in the genomics space, and the company is busy stocking its sandbox with all the best toys. Google Genomics and Tute Genomics have announced that a Tute database of 8.5 billion annotations of genetic variants is publicly available through Google Genomics. The database will be … Continue reading PRESS RELEASE: Tute Genomics Shares Database of 8.5 Billion Genetic Variants on Google Genomics